A few days ago we published the editorial for the latest issues of the Nepal Journal of Epidemiology. This editorial under the title ‘Urgent need for better quality control, standards and regulation for the Large Language Models used in healthcare domain‘ [1] comments that current methodologies for ensuring AI (Artificial Intelligence) technology’s safety and efficacy may be adequate for earlier AI iterations predating generative artificial intelligence (GAI). However, better clinical gouvernance GAI may necessitate the development of novel regulatory frameworks. As AI technology advances, researchers, academic institutions, funding bodies, and publishers should continue to examine its impact on scientific inquiry and revise their understanding, ethical guidelines, and regulations accordingly.
The co-authors include two Bournemouth University Visiting Faculty, Prof. Padam Simkhada (based at the University of Huddersfield) and Dr. Brijesh Sathian (based at Rumailah Hospital, Qatar).
Prof. Edwin van Teijlingen
CMWH
Reference:
- Sathian, B., van Teijlingen, E., do Nascimento, I. J. B., Kabir, R., Banerjee, I., Simkhada, P., & Al Hamad, H. (2024). Urgent need for better quality control, standards and regulation for the Large Language Models used in healthcare domain. Nepal Journal of Epidemiology, 14(2), 1310–1312. https://doi.org/10.3126/nje.v14i2.69361
Impact Factor for Nepal Journal of Epidemiology
Congratulations to Prof. Bouchachia on latest paper
Editorial accepted by Frontiers in Public Health










From Sustainable Research to Sustainable Research Lives: Reflections from the SPROUT Network Event
REF Code of Practice consultation is open!
BU Leads AI-Driven Work Package in EU Horizon SUSHEAS Project
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease